Sarasota, FL11 Active Studies

Ankylosing Spondylitis Clinical Trials in Sarasota, FL

Find 11 actively recruiting ankylosing spondylitis clinical trials in Sarasota, FL. Connect with local research sites and explore new treatment options.

11
Active Trials
10
Sponsors
3,173
Enrolling

Recruiting Ankylosing Spondylitis Studies in Sarasota

About Ankylosing Spondylitis Clinical Trials in Sarasota

Ankylosing spondylitis is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, causing pain, stiffness, and potentially spinal fusion. It typically begins in early adulthood. Treatment includes NSAIDs, biologics (TNF and IL-17 inhibitors), and physical therapy.

There are currently 11 ankylosing spondylitis clinical trials recruiting participants in Sarasota, FL. These studies are seeking a combined 3,173 participants. Research is being sponsored by United Therapeutics, Genentech, Inc., Janssen Research & Development, LLC and 7 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Ankylosing Spondylitis Clinical Trials in Sarasota — FAQ

Are there ankylosing spondylitis clinical trials in Sarasota?

Yes, there are 11 ankylosing spondylitis clinical trials currently recruiting in Sarasota, FL. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Sarasota?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Sarasota research site will contact you about next steps.

Are clinical trials in Sarasota free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Sarasota studies also compensate for your time and travel.

What ankylosing spondylitis treatments are being tested?

The 11 active trials in Sarasota are testing new therapies including novel drugs, biologics, and treatment approaches for ankylosing spondylitis.

Data updated July 19, 2026 from ClinicalTrials.gov